Cryo Cell International (CCEL) Change in Accured Expenses (2010 - 2026)

Cryo Cell International has disclosed Change in Accured Expenses across 17 years of filings, most recently posting -$1.4 million for Q1 2026.

• In Q1 2026, Change in Accured Expenses rose 5.59% year-over-year to -$1.4 million; the TTM figure through Feb 2026 stood at -$1.4 million (down 569.97% YoY), while the FY2025 annual figure was -$1.5 million, down 54926.23% from the prior year.
• Change in Accured Expenses retreated to -$1.4 million in Q1 2026, from $2.0 million in the prior quarter.
• Over the last five years, Change in Accured Expenses for CCEL reached as high as $3.4 million in Q4 2023 and fell as low as -$2.5 million in Q3 2024.
• The 5-year median for Change in Accured Expenses is -$445135.0 (2023), against an average of -$47597.6.
• Annual changes were most pronounced in 2022 — Change in Accured Expenses soared 708.73% — and 2023, when it plunged 2862.7%.
• A 5-year view of Change in Accured Expenses shows it stood at $1.4 million in 2022, then surged by 142.47% to $3.4 million in 2023, then slipped by 26.6% to $2.5 million in 2024, then dropped by 20.04% to $2.0 million in 2025, then slumped by 169.76% to -$1.4 million in 2026.
• According to Business Quant data, Change in Accured Expenses over the past three periods registered -$1.4 million, $2.0 million, and -$389123.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.